IPXL
Impax Laboratories, Inc.
IPXL
IPXL
Delisted
IPXL was delisted on the 4th of May, 2018.
162 hedge funds and large institutions have $1.42B invested in Impax Laboratories, Inc. in 2014 Q3 according to their latest regulatory filings, with 17 funds opening new positions, 53 increasing their positions, 74 reducing their positions, and 39 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
162
Holders Change
-23
Holders Change %
-12.43%
% of All Funds
4.7%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
17
Increased
53
Reduced
74
Closed
39
Calls
$20.9M
Puts
$2.3M
Net Calls
+$18.6M
Net Calls Change
+$20.3M
Top Buyers
| 1 |
SPC
Slate Path Capital
New York
|
$55.2M |
| 2 |
O
OrbiMed
New York
|
$152M |
| 3 |
TGI
Tradewinds Global Investors
Los Angeles,
California
|
$21.8M |
| 4 |
TCM
Tekla Capital Management
Boston,
Massachusetts
|
$23.5M |
| 5 |
Invesco
Atlanta,
Georgia
|
$84.8M |
